Journal: Molecular Cancer Research
Article Title: Heme Sequestration Effectively Suppresses the Development and Progression of Both Lung Adenocarcinoma and Squamous Cell Carcinoma
doi: 10.1158/1541-7786.mcr-21-0385
Figure Lengend Snippet: Figure 4. The levels of representative metabolic proteins and enzymes in ADC and SCC tumors developed in KLLuc mice. A, Representative IHC images of lung tissue sections showing levels of glucose transporter SLC2A1, along with the ADC marker NKX2-1 and the SCC marker DNp63, from KLLuc mice at 10 weeks after the initiation of tumorigenesis via viral infection. B, Representative IHC images of lung tissue sections showing levels of glutamine transporter SLC1A5, along with the ADC marker NKX2-1 and the SCC marker DNp63, from KLLuc mice at 10 weeks after the initiation of tumorigenesis via viral infection. C, Representative IHC images of lung tissue sections showing levels of ALAS1, along with the ADC marker NKX2-1 and the SCC marker DNp63, from KLLuc mice at 10 weeks after the initiation of tumorigenesis via viral infection. D, Representative IHC images of lung tissue sections showing levels of SLC48A1, along with the ADC marker NKX2-1 and the SCC marker DNp63, from KLLuc mice at 10 weeks after the initiation of tumorigenesis via viral infection. E, Representative IHC images of lung tissue sections showing levels of COX5A, along with the ADC marker NKX2-1 and the SCC marker DNp63, from KLLuc mice at 10 weeks after the initiation of tumorigenesis via viral infection. Shown are montage and 10 images of lung tissue sections stained with DAPI (row 1), antibodies to NKX2-1 or DNp63 (row 2), antibodies to the indicated protein (row 3), and merged images of NKX2-1 or DNp63 with the indicated protein (row 4). The light green lines in DAPI montage images outline the tumors in the lung. The white arrows denote the regions shown in 10 images. Scale bar, montage, 1 mm; 10, 100 mm. F, Graph showing quantified levels of SLC2A1 in ADC and SCC tumors correlating with A. G, Graph showing quantified levels of SLC1A5 in ADC and SCC tumors correlating with B. H, Graph showing quantified levels of ALAS1 in ADC and SCC tumors correlating with C. I, Graph showing quantified levels of SLC48A1 in ADC and SCC tumors correlating with D. J, Graph showing quantified levels of COX5A in ADC and SCC tumors correlating with E. Protein levels were quantified, and data are plotted as mean SEM.
Article Snippet: The dilutions were 1:100 DeltaNp63 (Abcam cat. D ow nloaded from http://aacrjournals.org/m cr/article-pdf/20/1/139/3015029/139.pdf by guest on 20 February 2024 #ab172731, RRID:AB_2891015), 1:100 TTF-1 (Agilent cat. #M3575, RRID:AB_2877699), 1:200 Ki-67 (Cell Signaling Technology cat. #12202, RRID:AB_2620142), 1:200 cleaved caspase-3 (Cell Signaling Technology cat. #9661, RRID:AB_2341188), 1:100 Alas1 (Novus cat. #NB100-56415, RRID:AB_837550), 1:200 SLC48A1 (Novus cat. #NBP1-91563, RRID:AB_11009875), 1:50 HCCS (Abcam cat. #ab224321, RRID:AB_2891018), 1:200 cytochrome c (Novus cat. #NBP2-21569, RRID:AB_2891022), 1:100 COX5A (Abcam cat. #ab110262, RRID:AB_10861723), 1:500 COX5B (Abcam cat. #ab180136, RRID:AB_2891023), 1:500 COX7B (Abcam cat. #ab137094, RRID:AB_2891024), 1:1,000 ATP5A (Abcam cat. #ab14748, RRID:AB_301447), 1:200 SLC2A1 (Abcam cat. #ab40084, RRID:AB_2190927), 1:500 HK2 (Thermo Fisher Scientific cat. #PA529326, RRID:AB_2546802), 1:200 SLC1A5 (Abcam cat. #ab58690, RRID:AB_943478), 1:200 GLS (Abcam cat. #ab156876, RRID: AB_2721038), 1:35 VEGFA (Abcam cat. #9570, RRID: AB_308723), 1:50 VEGFR1 (Abcam cat. #ab2350, RRID:AB_303000), 1:200 HIF1a (Novus Biologicals cat. #NB100-449, RRID: AB_10001045), 1:200 CA9 (Novus biologicals cat. #NB100-417, RRID:AB_ 10003398), 1:200 CD34 (Abcam cat. #ab185732, RRID:AB_2811308), and CD31 (PECAM1; Cell Signaling Technology cat. #77699, RRID: AB_2722705).
Techniques: Marker, Infection, Staining